...
首页> 外文期刊>Clinical transplantation. >Long-term outcomes of transplant recipients referred for angiography for suspected transplant renal artery stenosis
【24h】

Long-term outcomes of transplant recipients referred for angiography for suspected transplant renal artery stenosis

机译:因怀疑移植肾动脉狭窄而接受血管造影的移植接受者的长期结局

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Our aim was to study the long-term outcomes of all transplant recipients who underwent angiography for suspected TRAS at our institution. The patients were divided into TRAS+ve and TRAS-ve groups based upon angiographically confirmed results. TRAS was confirmed in 58.1% of 74 patients with median time of 8.9months. Primary angioplasty alone was performed in 56% of patients with TRAS, while the remaining had PTA with stent (PTAS). There was reduction in systolic and diastolic BP (165 +/- 19-136 +/- 15mmHg and 82 +/- 14mmHg to 68 +/- 12mmHg; p<0.05) and number of antihypertensive drugs (3.5 +/- 0.9-2.7 +/- 1.0; p<0.05). Overall, graft survival and patient survival from time of transplant were similar in both groups. Graft function was similar for the patients with treated TRAS+ve as compared to TRAS-ve over time. Graft survival and patient survival when compared to an age- and year of transplant-matched cohort control group were also similar. In conclusion, angiography for suspected TRAS is more likely to yield a confirmatory result early in the transplant course as compared to late. Treatment of TRAS in these patients had sustained long-term graft function. Alternative etiologies of HTN and graft dysfunction should be sought for recipients further out from transplant.
机译:我们的目的是研究我们机构中所有因疑似TRAS接受了血管造影的移植接受者的长期结果。根据血管造影结果将患者分为TRAS + ve组和TRAS-ve组。 74例患者中有58.1%确诊为TRAS,中位时间为8.9个月。在56%的TRAS患者中,仅进行了一次原发性血管成形术,而其余患者则采用了带支架的PTA(PTAS)。收缩压和舒张压降低(165 +/- 19-136 +/- 15mmHg和82 +/- 14mmHg降至68 +/- 12mmHg; p <0.05)和降压药数量减少(3.5 +/- 0.9-2.7 +/- 1.0; p <0.05)。总体而言,两组的移植物存活率和移植后患者的存活率相似。经治疗的TRAS + ve患者的移植物功能与经时的TRAS-ve患者相似。与同年龄和年份的移植匹配队列对照组相比,移植物存活率和患者存活率也相似。总之,与晚期相比,可疑TRAS的血管造影更可能在移植过程的早期产生确认结果。这些患者的TRAS治疗具有持续的长期移植功能。对于远离移植的接受者,应寻求替代性的HTN病因和移植物功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号